SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5.51 |
Enterprise Value ($M) | 3.22 |
Book Value ($M) | 1.96 |
Book Value / Share | 0.36 |
Price / Book | 2.81 |
NCAV ($M) | 1.24 |
NCAV / Share | 0.23 |
Price / NCAV | 4.45 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -8.84 |
Return on Assets (ROA) | -0.88 |
Return on Equity (ROE) | -1.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.53 |
Current Ratio | 1.53 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.58 |
Assets | 4.30 |
Liabilities | 2.34 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -16.45 |
Net Income | -17.29 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -14.09 |
Cash from Investing | 0.01 |
Cash from Financing | -1.34 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Armistice Capital, Llc | 9.99 | ||
13G/A | Intracoastal Capital, Llc | 6.20 | -29.66 | |
13G/A | Hudson Bay Capital Management LP | 4.54 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
40,195 | 248,917 | 16.15 | |
93,593 | 369,471 | 25.33 | |
45,728 | 262,436 | 17.42 | |
121,424 | 445,030 | 27.28 | |
(click for more detail) |
Similar Companies | |
---|---|
ENLV – Enlivex Therapeutics Ltd. | ENSC – Ensysce Biosciences, Inc. |
ENTX – Entera Bio Ltd. | EPIX – ESSA Pharma Inc. |
EQ – Equillium, Inc. |
Financial data and stock pages provided by
Fintel.io